Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.

By D. Hackam, Sonia S Anand. Journal of the American Medical Association (JAMA), 2003

630 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/7ec1010d084799b32fd917abc8625d54a1489bc0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Mitchell S. V. Elkind
2. Christie M. Ballantyne
3. J. Keaney

Citations in the corpus

• Reactive Oxygen Species in Cardiovascular Disease (2011, background): “It remains to be seen if consideration of these ROS-sensitive biomarkers can add clinically important information to patient care [226].”
• Criteria for Evaluation of Novel Markers of Cardiovascular Risk (2009, background): “A relationship is considered to be “significant” if (1) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (2) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the en”